Oragenics Inc
OGEN- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001174940
No open-market purchases or sales by Oragenics Inc insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $39.2K in total; no superinvestor holds it.
Holders of 5% or more of OGEN
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Oragenics Inc, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Five Narrow Lane LP | 13G | 9.99%82.2K shares | New | Jul 2, 20251 filing | Jul 2, 2025 | SEC |
| Sabby Management, LLC | 13G | 9.90%412.7K shares | New | Jan 21, 20261 filing | Jan 21, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
2 Schedule 13D and 13G filings on Oragenics Inc, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Jan 21, 202610:14 AM ET | Sabby Management, LLCand 2 others | 13G | 9.90%412.7K shares | New | Dec 31, 2025 | SEC |
| Jul 2, 20252:43 PM ET | Five Narrow Lane LP | 13G | 9.99%82.2K shares | New | Jul 2, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Oragenics Inc shares.
No Form 144 notices for Oragenics Inc are on file.